Lumenis Unveils Enhanced SPLENDOR XTM Laser Hair Removal Solution With New Clinical Data At The Annual American Society For Laser Medicine And Surgery (ASLMS) Conference
"Laser hair removal consistently remains a top-demand procedure and as a provider, I'm looking for a solution that can cater to a diverse patient population and still achieve optimal results," said Dr. Anne Chapas, M.D., board-certified dermatologist, founder and medical director of Union Square Laser Dermatology. "As one of the clinical sites in the BLEND X ® study, we've already experienced the benefits of this technology in terms of superior hair reduction as well as the ability to tailor the parameters for each patient's needs."
The new edition of the SPLENDOR XTM solution is now available in both the U.S. and Canada, featuring new, innovative patient- and provider-centric features such as preset parameters for laser hair removal and vascular treatments. The U.S. edition also offers new digital capabilities enabling improved system uptime and advanced data services for large accounts.
Tzipi Ozer-Armon, CEO of Lumenis added, "Lumenis is a pioneer in the laser hair removal industry, and with this launch we are thrilled to deliver on our promise to continuously innovate and elevate hair removal treatment to a whole new level. The clinical evidence confirms that our unique simultaneous, dual wavelength BLEND X® technology, the first and only FDA-cleared one of its kind, offers improved results, empowering providers and patients alike with the knowledge that these safe, comfortable, and effective treatments will enable patients to exude confidence and look radiant."
Presentation details below:
Date & Time: Thursday, April 24, 2025, from 2:20 PM - 2:24 PM EST
Session Title: Use OF Simultaneous Emission of ND: YAG and Alexandrite Lasers in Blend More for Hair Removal and Permanent Hair Reduction
Presenting Author: Nkemjika Ugonabo, MD, MPH
To learn more about SPLENDOR XTM and BLEND X ® , visit
About Lumenis
Lumenis is a global leader in the medical aesthetics and eye care markets and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radiofrequency (RF). For more than 50 years, Lumenis' ground-breaking products have redefined medical treatments and set technological and clinical gold-standards, revolutionizing existing treatment methods, and creating solutions for previously untreatable conditions. Lumenis is a portfolio company of EQT Private Capital Asia. For more information regarding Lumenis' range of clinical solutions, please visit: .
About SPLENDOR XTM
SPLENDOR XTM is unlike any other Alexandrite and Nd:YAG system for laser hair removal (LHR), benign dermatological vascular lesions, and more. Introduced by LUMENIS, a global leader in laser and energy-based technologies, it is the only Alexandrite and Nd:YAG laser system powered by BLEND X ® technology for unprecedented power, speed, efficacy and versatility. SPLENDOR XTM lets you customize and tailor laser hair removal and other treatments across a wide range of skin tones, like never before. It is an innovative square fiber-delivered laser system featuring optimal skin coverage by large, square spots, providing safe, efficient treatments thanks to unique energy management, together with an integrated plume evacuator and supporting an optimal patient experience by a Dual Cooling System (DCS).
*For safety information and Instructions for Use, please refer to the User Manual and Treatment Guidelines provided with your SPLENDOR XTM device. The User Manual includes warning and cautions that are important to ensure your safety and the safety of your patients.
Media Contact
Erick Edwing, [email protected]
SOURCE Lumenis Be. Ltd.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment